Amerigroup
Managed healthcare company Amerigroup (AGP), which has a specialty in providing publicly funded healthcare programs to Medicaid and Children's Health Insurance recipients is Morningstar's strongest healthcare takeover target because of an expected inflow of patients to the company when the Affordable Care Act becomes effective in 2014 [if it's not overturned.]
"Amerigroup - with its 2 million Medicaid members spread across 11 states - seems like a particularly attractive target," writes Morningstar.
A takeover could create back office efficiencies, while also providing a larger corporate managed healthcare provider an inroad into growing publicly funded healthcare programs. "[The] company has specialized expertise that could enable a historically commercial-market-focused peer such as Aetna (AET) to compete in the Medicaid business," adds Morningstar. Currently, Morningstar also sees Amerigroup shares as 20% undervalued, even without a M&A catalyst. Morningstar gives Amerigroup a three star rating and a fair value of $76 a share, a near 10% premium to its current share price of $69.78. The company is expected to earn $61 cents a share in its fourth quarter 2011 results due on Feb. 17, according to Zacks consensus estimates. Analysts give the company an estimated price target of $68 a share on 2012 revenue of $8.2 billion and profit of $188 million, according to data compiled by Bloomberg. For more on managed healthcare sector shares, see TheStreet's portfolio of top-rated managed healthcare stocks.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV